Concepedia

Antonio Giordano

AG

Statistics

Publications

8

Citations

246

H-Index

8

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

European Institute of Oncology

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Antonio Giordano is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and breast oncology.

Publications per year

2016–2025

8

Publications

8

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer

Michal Mego, Hui Gao, Evan N. Cohen et al. · Oncotarget · 2016 · 72 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

Antonio Giordano, Yueying Liu, Kent Armeson et al. · PLoS ONE · 2019 · 45 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer

Giuseppe Curigliano, Geoffrey I. Shapiro, Rebecca Kristeleit et al. · British Journal of Cancer · 2022 · 34 citations · Full text

Medicine, Oncology, Pharmacology +10

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience

Laura Pizzuti, Antonio Giordano, Andrea Michelotti et al. · Journal of Cellular Physiology · 2018 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15

HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications

Paolo Tarantino, Samuel M. Niman, Timothy K. Erick et al. · European Journal of Cancer · 2022 · 20 citations

Medicine, Oncology, Pathology +16

1–5 of 8